Novel therapeutic targets in rheumatoid arthritis

被引：138
|
作者：
Koenders, Marije I. [1 ]
van den Berg, Wim B. [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Expt Rheumatol, NL-6525 ED Nijmegen, Netherlands
来源：
TRENDS IN PHARMACOLOGICAL SCIENCES | 2015年 / 36卷 / 04期
关键词：
rheumatoid arthritis; therapeutic targets; JAK; Th17; IL-17; ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; MODIFYING ANTIRHEUMATIC DRUGS; DOUBLE-BLIND; PHASE-II; T-CELLS; INADEQUATE RESPONSE; TH17; CELLS; EULAR RECOMMENDATIONS; PSORIATIC-ARTHRITIS; JOINT INFLAMMATION;
D O I：
10.1016/j.tips.2015.02.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Rheumatoid arthritis (RA) is an autoimmune disease that leads to inflammation and destruction of synovial joints. Despite the broad spectrum of antirheumatic drugs, this heterogeneous disease is still not well controlled in up to 30% of patients. Here, we discuss two pathways that are regarded as interesting novel therapeutic targets in the field of rheumatology: the Janus kinase (JAK) pathway and the T helper-17 (Th17) pathway [including interleukin (IL)-17, IL-21, IL-22, and granulocyte-macrophage colony-stimulating factor (GM-CSF)]. We also review the therapy potential of biologicals and small-molecule inhibitors blocking these pathways. Advances in combination therapy in addition to progress in biomarker screening will help us to further achieve effective and personalized healthcare for patients with RA.
引用
收藏
页码：189 / 195
页数：7
相关论文
共 50 条
  • [31] Cytokines as Therapeutic Targets in Rheumatoid Arthritis and Other Inflammatory Diseases
    Siebert, Stefan
    Tsoukas, Alexander
    Robertson, Jamie
    McInnes, Iain
    [J]. PHARMACOLOGICAL REVIEWS, 2015, 67 (02) : 280 - 309
  • [32] Promising bone-related therapeutic targets for rheumatoid arthritis
    Choi, Yongwon
    Arron, Joseph R.
    Townsend, Michael J.
    [J]. NATURE REVIEWS RHEUMATOLOGY, 2009, 5 (10) : 543 - 548
  • [33] Therapeutic targets for rheumatoid arthritis: lessons from animal models
    Iwakura, Yoichiro
    Saijo, Shinobu
    Nakae, Susumu
    Fujikado, Noriyuki
    Ishigame, Harumichi
    Murayama, Masanori
    [J]. ARTHRITIS RESEARCH & THERAPY, 2012, 14
  • [34] Interleukins and Janus Kinases: Emerging Therapeutic Targets in Rheumatoid Arthritis
    Mansukhani, Rupal
    [J]. AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 (14): : S454 - S461
  • [35] Cytokines in the pathogenesis of rheumatoid arthritis: New players and therapeutic targets
    Alunno A.
    Carubbi F.
    Giacomelli R.
    Gerli R.
    [J]. BMC Rheumatology, 1 (1)
  • [36] Therapeutic targets for rheumatoid arthritis: lessons from animal models
    Yoichiro Iwakura
    Shinobu Saijo
    Susumu Nakae
    Noriyuki Fujikado
    Harumichi Ishigame
    Masanori Murayama
    [J]. Arthritis Research & Therapy, 14 (Suppl 1):
  • [37] Cellular and Intercellular Signaling in Rheumatoid Arthritis - New Therapeutic Targets
    Szechinski, Jacek
    Szmyrka-Kaczmarek, Magdalena
    Gruszecka, Beata
    [J]. ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, 2008, 17 (04): : 379 - 386
  • [38] T cells: Pathogenic cells and therapeutic targets in rheumatoid arthritis
    Yocum, DE
    [J]. SEMINARS IN ARTHRITIS AND RHEUMATISM, 1999, 29 (01) : 27 - 35
  • [39] KCa1.1 channels as therapeutic targets for rheumatoid arthritis
    Beeton, Christine
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2017, 21 (12) : 1077 - 1081
  • [40] TRISTETRAPROLIN IS A NOVEL THERAPEUTIC TARGET FOR RHEUMATOID ARTHRITIS
    Ross, E. A.
    Smallie, T.
    Naylor, A. J.
    Desanti, G. E.
    Crowe, J.
    O'Neil, J. D.
    Turner, J. D.
    Yemm, A.
    Norling, L. V.
    Perlman, H.
    Verrills, N. M.
    Filer, A.
    Dean, J. L.
    Buckley, C. D.
    Clark, A. R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : A81 - A81
12345